Blood tests during immunotherapy reveal inflammation patterns.
NCT ID NCT05707286
First seen Jan 07, 2026 · Last updated Apr 29, 2026 · Updated 23 times
Summary
This study looked at 98 adults with cancers like melanoma and lung cancer who were starting immunotherapy. Researchers took blood samples to measure inflammatory proteins (cytokines) over time. The goal was to understand how these markers relate to side effects, helping doctors manage treatment better in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, 46202, United States
Conditions
Explore the condition pages connected to this study.